-
Je něco špatně v tomto záznamu ?
Identification of Eukaryotic Translation Elongation Factor 1-α 1 Gamendazole-Binding Site for Binding of 3-Hydroxy-4(1 H)-quinolinones as Novel Ligands with Anticancer Activity
K. Burglová, G. Rylová, A. Markos, H. Prichystalova, M. Soural, M. Petracek, M. Medvedikova, G. Tejral, B. Sopko, P. Hradil, P. Dzubak, M. Hajduch, J. Hlavac,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NV17-32285A
MZ0
CEP - Centrální evidence projektů
NV17-32285A
MZ0
CEP - Centrální evidence projektů
- MeSH
- chinolony chemická syntéza farmakologie MeSH
- elongační faktor 1 biosyntéza účinky léků MeSH
- indazoly metabolismus MeSH
- lidé MeSH
- ligandy MeSH
- molekulární konformace MeSH
- molekulární modely MeSH
- nádorové buněčné linie MeSH
- protinádorové látky chemická syntéza farmakologie MeSH
- vazebná místa účinky léků MeSH
- výpočetní biologie MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Here, we have identified the interaction site of the contraceptive drug gamendazole using computational modeling. The drug was previously described as a ligand for eukaryotic translation elongation factor 1-α 1 (eEF1A1) and found to be a potential target site for derivatives of 2-phenyl-3-hydroxy-4(1 H)-quinolinones (3-HQs), which exhibit anticancer activity. The interaction of this class of derivatives of 3-HQs with eEF1A1 inside cancer cells was confirmed via pull-down assay. We designed and synthesized a new family of 3-HQs and subsequently applied isothermal titration calorimetry to show that these compounds strongly bind to eEF1A1. Further, we found that some of these derivatives possess significant in vitro anticancer activity.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19028537
- 003
- CZ-PrNML
- 005
- 20201014123233.0
- 007
- ta
- 008
- 190813s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1021/acs.jmedchem.8b00078 $2 doi
- 035 __
- $a (PubMed)29498519
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Burglová, Kristyna $u Institute of Molecular and Translation Medicine, Faculty of Medicine and Dentistry , Palacký University , Hněvotínská 5 , 779 00 Olomouc , Czech Republic.
- 245 10
- $a Identification of Eukaryotic Translation Elongation Factor 1-α 1 Gamendazole-Binding Site for Binding of 3-Hydroxy-4(1 H)-quinolinones as Novel Ligands with Anticancer Activity / $c K. Burglová, G. Rylová, A. Markos, H. Prichystalova, M. Soural, M. Petracek, M. Medvedikova, G. Tejral, B. Sopko, P. Hradil, P. Dzubak, M. Hajduch, J. Hlavac,
- 520 9_
- $a Here, we have identified the interaction site of the contraceptive drug gamendazole using computational modeling. The drug was previously described as a ligand for eukaryotic translation elongation factor 1-α 1 (eEF1A1) and found to be a potential target site for derivatives of 2-phenyl-3-hydroxy-4(1 H)-quinolinones (3-HQs), which exhibit anticancer activity. The interaction of this class of derivatives of 3-HQs with eEF1A1 inside cancer cells was confirmed via pull-down assay. We designed and synthesized a new family of 3-HQs and subsequently applied isothermal titration calorimetry to show that these compounds strongly bind to eEF1A1. Further, we found that some of these derivatives possess significant in vitro anticancer activity.
- 650 _2
- $a protinádorové látky $x chemická syntéza $x farmakologie $7 D000970
- 650 _2
- $a vazebná místa $x účinky léků $7 D001665
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a výpočetní biologie $7 D019295
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a indazoly $x metabolismus $7 D007191
- 650 _2
- $a ligandy $7 D008024
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a molekulární konformace $7 D008968
- 650 _2
- $a elongační faktor 1 $x biosyntéza $x účinky léků $7 D020648
- 650 _2
- $a chinolony $x chemická syntéza $x farmakologie $7 D015363
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Rylová, Gabriela $u Institute of Molecular and Translation Medicine, Faculty of Medicine and Dentistry , Palacký University , Hněvotínská 5 , 779 00 Olomouc , Czech Republic.
- 700 1_
- $a Markos, Athanasios $u Institute of Molecular and Translation Medicine, Faculty of Medicine and Dentistry , Palacký University , Hněvotínská 5 , 779 00 Olomouc , Czech Republic.
- 700 1_
- $a Prichystalova, Hana $u Institute of Molecular and Translation Medicine, Faculty of Medicine and Dentistry , Palacký University , Hněvotínská 5 , 779 00 Olomouc , Czech Republic.
- 700 1_
- $a Soural, Miroslav $u Institute of Molecular and Translation Medicine, Faculty of Medicine and Dentistry , Palacký University , Hněvotínská 5 , 779 00 Olomouc , Czech Republic.
- 700 1_
- $a Petracek, Marek $u Institute of Molecular and Translation Medicine, Faculty of Medicine and Dentistry , Palacký University , Hněvotínská 5 , 779 00 Olomouc , Czech Republic.
- 700 1_
- $a Medvedikova, Martina $u Institute of Molecular and Translation Medicine, Faculty of Medicine and Dentistry , Palacký University , Hněvotínská 5 , 779 00 Olomouc , Czech Republic.
- 700 1_
- $a Tejral, Gracian $u Department of Biophysics, Second Faculty of Medicine , Charles University , V Úvalu 84 , 150 06 Praha 5 , Czech Republic. Department of Tissue Engineering , The Czech Academy of Sciences, Institute of Experimental Medicine , Vídeňská 1083 , 142 20 Praha 4 , Czech Republic. University Center for Energy Efficient Buildings (UCEEB) , The Czech Technical University in Prague , Třinecká 1024 , 273 43 Bustehrad , Czech Republic.
- 700 1_
- $a Sopko, Bruno $u Department of Medical Chemistry and Clinical Biochemistry, Second Faculty of Medicine , Charles University and Motol University Hospital , V Úvalu 84 , 150 06 Praha 5 , Czech Republic. Department of Tissue Engineering , The Czech Academy of Sciences, Institute of Experimental Medicine , Vídeňská 1083 , 142 20 Praha 4 , Czech Republic. $7 xx0250670
- 700 1_
- $a Hradil, Pavel $u Institute of Molecular and Translation Medicine, Faculty of Medicine and Dentistry , Palacký University , Hněvotínská 5 , 779 00 Olomouc , Czech Republic.
- 700 1_
- $a Dzubak, Petr $u Institute of Molecular and Translation Medicine, Faculty of Medicine and Dentistry , Palacký University , Hněvotínská 5 , 779 00 Olomouc , Czech Republic.
- 700 1_
- $a Hajduch, Marian $u Institute of Molecular and Translation Medicine, Faculty of Medicine and Dentistry , Palacký University , Hněvotínská 5 , 779 00 Olomouc , Czech Republic.
- 700 1_
- $a Hlavac, Jan $u Department of Organic Chemistry, Faculty of Science , Palacký University , Tř. 17. listopadu 12 , 771 46 Olomouc , Czech Republic.
- 773 0_
- $w MED00010049 $t Journal of medicinal chemistry $x 1520-4804 $g Roč. 61, č. 7 (2018), s. 3027-3036
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29498519 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20201014123229 $b ABA008
- 999 __
- $a ok $b bmc $g 1433686 $s 1066997
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 61 $c 7 $d 3027-3036 $e 20180316 $i 1520-4804 $m Journal of medicinal chemistry $n J Med Chem $x MED00010049
- GRA __
- $a NV16-29680A $a NV17-32285A $p MZ0 $p MZ0
- GRA __
- $a NV16-29680A $a NV17-32285A $p MZ0 $p MZ0
- LZP __
- $a Pubmed-20190813